India's pharmaceutical sector boasts a complex landscape, where the presence of both significant global players and a multitude of domestic entities creates a dynamic yet often fragmented market. While this range can foster advancement, concerns regarding monopoly power are increasingly coming to the surface. A handful of corporations have managed